Follow the Accretive Health, Inc. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was reported on 12 February 2016 (Retenue fiscale). Among the most active insiders: FLANAGAN JOSEPH GERARD. All data is free.
10
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Accretive Health, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Fundamental score
Ranked 27,133 of 28,958 companies
17.5
score / 100
Value
23
Quality
12
FCF yld-4.0%
Earn yld-5.1%
EV/EBITDA·
ROE-40%
Gross mgn13%
Net mgn-8.8%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Accretive Health, Inc. is a company focused on revenue cycle management and healthcare services. It assists healthcare providers in enhancing their financial and operational performance.